Tag: Prescription Drugs
Verubecestat, Atabecestat Not Beneficial for Preventing Alzheimer Disease
Two trials show lack of effectiveness versus placebo for preclinical Alzheimer disease
High Response Seen for All Hep C Tx Models in Injection Drug Users
Directly observed therapy tied to greater adherence than self-administered individual treatment
More Secondary Prevention Meds May Reduce Deaths After AMI
Mortality lower with more meds for older nursing home residents after acute myocardial infarction
Many NPs Unable to Prescribe Meds to Treat Opioid Addiction
Greater practice restrictions lead to lower percentage of NPs with waivers to prescribe buprenorphine
Preventive Drugs Often Used in Last Year of a Cancer Patient’s Life
Preventive drugs, including antihypertensives and statins, frequently continued until final month of life
No Benefit Seen With Rituximab for Chronic Fatigue Syndrome
B-cell depletion using several rituximab infusions over 12 months not linked to clinical improvement
American Association for Cancer Research, March 29-April 3
The American Association for Cancer Research Annual Meeting The annual meeting of the American Association for Cancer Research was held from March 29...
Patient-Report Instrument Helps Identify ADEs in Older Adults
With accuracy of 75 percent, tool differentiates between symptoms of adverse drug events, chronic disease
Beta Interferon Tied to Lower Mortality in Relapsing-Onset MS
Increased survival seen with more than three years of beta interferon exposure but not lower exposure
AACR: Pembrolizumab Beneficial for Advanced Small Cell Lung Cancer
Antitumor activity promising; objective response rate 19.3 percent for patients with incurable, advanced SCLC
